Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma

Clinical Trial ID NCT01330173

PubWeight™ 9.53^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01330173

Top papers